Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes
- 3 September 2020
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 46 (07) , 807-814
Abstract
The proinflammatory cytokine storm associated with coronavirus disease 2019 (COVID-19) negatively affects the hematological system, leading to coagulation activation and endothelial dysfunction and thereby increasing the risk of venous and arterial thrombosis. Coagulopathy has been reported as associated with mortality in people with COVID-19 and is partially reflected by enhanced D-dimer levels. Poor vascular health, which is associated with the cardiometabolic health conditions frequently reported in people with severer forms of COVID-19, might exacerbate the risk of coagulopathy and mortality. Sedentary lifestyles might also contribute to the development of coagulopathy, and physical activity participation has been inherently lowered due to at-home regulations established to slow the spread of this highly infectious disease. It is possible that COVID-19, coagulation, and reduced physical activity may contribute to generate a “perfect storm,” where each fuels the other and potentially increases mortality risk. Several pharmaceutical agents are being explored to treat COVID-19, but potential negative consequences are associated with their use. Exercise is known to mitigate many of the identified side effects from the pharmaceutical agents being trialled but has not yet been considered as part of management for COVID-19. From the limited available evidence in people with cardiometabolic health conditions, low- to moderate-intensity exercise might have the potential to positively influence biochemical markers of coagulopathy, whereas high-intensity exercise is likely to increase thrombotic risk. Therefore, low- to moderate-intensity exercise could be an adjuvant therapy for people with mild-to-moderate COVID-19 and reduce the risk of developing severe symptoms of illness that are associated with enhanced mortality. Publication Date: 03 September 2020 (online) Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Keywords
This publication has 104 references indexed in Scilit:
- Effect of Marathon Run and Air Travel on Pre- and Post-Run Soluble D-Dimer, Microparticle Procoagulant Activity, and P-Selectin LevelsThe American Journal of Cardiology, 2012
- Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy AdultsMedicine & Science in Sports & Exercise, 2011
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Exercise and Physical Activity for Older AdultsMedicine & Science in Sports & Exercise, 2009
- Tocilizumab: The first interleukin-6-receptor inhibitorAmerican Journal of Health-System Pharmacy, 2008
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA StudyPreventive Medicine, 2005
- Influence of an Acute Exercise on Neutrophil and Platelet Adhesion, Nitric Oxide Plasma Metabolites in Inactive and Active SubjectsInternational Journal of Sports Medicine, 2000
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Effects of Exercise on Blood Coagulation, Fibrinolysis and Platelet AggregationSports Medicine, 1996